Search research articles
Contact Us
Filters
Showing results (121-130 of 324) with videos related to
Page
of 33
Sort By:
Plos One
|
November 16, 2013
Linkage to HIV, TB and non-communicable disease care from a mobile testing unit in Cape Town, South Africa
Darshini Govindasamy, Katharina Kranzer, Nienke van Schaik, et al.
American Journal of Epidemiology
|
July 16, 2016
Can the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling Analysis
Nadia N Abuelezam, Alethea W McCormick, Thomas Fussell, et al.
Annals of the American Thoracic Society
|
February 21, 2026
Potential long-acting tuberculosis treatment for people with HIV: cost-effectiveness benchmarks
Amy Zheng, Eden Pletner, Keren Middelkoop, et al.
AIDS Care
|
May 28, 2019
HIV testing in a large community health center serving a multi-cultural patient population: A qualitative study of providers
Anthony J James, Danelle Marable, Caroline V Cubbison, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care
|
October 10, 2017
The patient-centered medical home: a reality for HIV care in Nigeria
Aima A Ahonkhai, Ifeyinwa Onwuatuelo, Susan Regan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 9, 2009
Loss to care and death before antiretroviral therapy in Durban, South Africa
Ingrid V Bassett, Bingxia Wang, Senica Chetty, et al.
Journal of Virus Eradication
|
February 16, 2016
The HIV Cure Research Agenda: The Role of Mathematical Modelling and Cost-Effectiveness Analysis
Kenneth A Freedberg, Cristina Possas, Steven Deeks, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 14, 2015
The clinical role and cost-effectiveness of long-acting antiretroviral therapy
Eric L Ross, Milton C Weinstein, Bruce R Schackman, et al.
Antiviral Therapy
|
June 3, 2010
CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trials
Yazdan Yazdanpanah, Lindsey L Wolf, Xavier Anglaret, et al.
The International Journal on Drug Policy
|
May 16, 2019
Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids
Joshua A Barocas, Jake R Morgan, David A Fiellin, et al.
Page
of 33
Search research articles
Search
Showing results (121-130 of 324) with videos related to
Sort By:
Page
of 33
Plos One
|
November 16, 2013
Linkage to HIV, TB and non-communicable disease care from a mobile testing unit in Cape Town, South Africa
Darshini Govindasamy, Katharina Kranzer, Nienke van Schaik, et al.
American Journal of Epidemiology
|
July 16, 2016
Can the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling Analysis
Nadia N Abuelezam, Alethea W McCormick, Thomas Fussell, et al.
Annals of the American Thoracic Society
|
February 21, 2026
Potential long-acting tuberculosis treatment for people with HIV: cost-effectiveness benchmarks
Amy Zheng, Eden Pletner, Keren Middelkoop, et al.
AIDS Care
|
May 28, 2019
HIV testing in a large community health center serving a multi-cultural patient population: A qualitative study of providers
Anthony J James, Danelle Marable, Caroline V Cubbison, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care
|
October 10, 2017
The patient-centered medical home: a reality for HIV care in Nigeria
Aima A Ahonkhai, Ifeyinwa Onwuatuelo, Susan Regan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 9, 2009
Loss to care and death before antiretroviral therapy in Durban, South Africa
Ingrid V Bassett, Bingxia Wang, Senica Chetty, et al.
Journal of Virus Eradication
|
February 16, 2016
The HIV Cure Research Agenda: The Role of Mathematical Modelling and Cost-Effectiveness Analysis
Kenneth A Freedberg, Cristina Possas, Steven Deeks, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 14, 2015
The clinical role and cost-effectiveness of long-acting antiretroviral therapy
Eric L Ross, Milton C Weinstein, Bruce R Schackman, et al.
Antiviral Therapy
|
June 3, 2010
CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trials
Yazdan Yazdanpanah, Lindsey L Wolf, Xavier Anglaret, et al.
The International Journal on Drug Policy
|
May 16, 2019
Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids
Joshua A Barocas, Jake R Morgan, David A Fiellin, et al.
Page
of 33